Not applicableStudy completedNCT03328195What this trial is testingVielight Neuro RX Gamma - Feasibility PilotWho this might be right forAlzheimer Disease Vielight Inc. 60
Large-scale testing (Phase 3)Study completedNCT00478205What this trial is testingComparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eisai Inc. 1,467
Large-scale testing (Phase 3)Not Yet RecruitingNCT05303701What this trial is testingGV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)Who this might be right forModerate to Severe Alzheimer's Disease Samsung Pharmaceutical Co., Ltd. 750
Testing effectiveness (Phase 2)Looking for participantsNCT06745583What this trial is testingAssess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsWho this might be right forMild, Moderate, or Severe Alzheimer's Disease Elixiron Immunotherapeutics (Hong Kong) Ltd. 15
Large-scale testing (Phase 3)WithdrawnNCT04187547What this trial is testingA Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label ExtensionWho this might be right forAlzheimer's Disease Cerecin
Not applicableStudy completedNCT01081743What this trial is testingEffectiveness of Care Management in Alzheimer PatientsWho this might be right forAlzheimer Disease or Associated DisorderMild to Moderately Severe Dementia Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Large-scale testing (Phase 3)Ended earlyNCT01066546What this trial is testingAn Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 5
Post-approval studies (Phase 4)UnknownNCT05430867What this trial is testingEfficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's DiseaseWho this might be right forTreatmentEfficacySafety+1 more First Affiliated Hospital Xi'an Jiaotong University 150
Large-scale testing (Phase 3)Study completedNCT00097916What this trial is testingAn Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Forest Laboratories 34
Post-approval studies (Phase 4)Study completedNCT00800709What this trial is testingMemantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Shanghai Mental Health Center 26
Large-scale testing (Phase 3)Ended earlyNCT00857649What this trial is testingEfficacy and Safety of Memantine in Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease H. Lundbeck A/S 369
Post-approval studies (Phase 4)UnknownNCT00866060What this trial is testingDonepezil and Memantine in Moderate to Severe Alzheimer's DiseaseWho this might be right forModerate to Severe Alzheimer's Disease King's College London 800
Post-approval studies (Phase 4)UnknownNCT01849042What this trial is testingEffect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseDementia Konkuk University Medical Center 188
Large-scale testing (Phase 3)Ended earlyNCT00679627What this trial is testingGalantamine Used to Treat Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Janssen Research & Development, LLC 2,051
Large-scale testing (Phase 3)Study completedNCT00322153What this trial is testingThe Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's DiseaseWho this might be right forDementia of the Alzheimer's Type Forest Laboratories 677
Testing effectiveness (Phase 2)Ended earlyNCT01766336What this trial is testingA 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease OPKO Health, Inc. 296
Large-scale testing (Phase 3)Ended earlyNCT00954590What this trial is testingA Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's DiseaseWho this might be right forModerate to Severe Alzheimer Medivation, Inc. 89
Post-approval studies (Phase 4)WithdrawnNCT00375557What this trial is testingSafety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia PatientsWho this might be right forAlzheimer's DiseaseDementiaBehavioral Symptoms University of Cincinnati
Large-scale testing (Phase 3)Ended earlyNCT00857233What this trial is testingSafety and Tolerability of Memantine in Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease H. Lundbeck A/S 297
Large-scale testing (Phase 3)Study completedNCT00090116What this trial is testingThe Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Forest Laboratories 400